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Background
Unhealthy drug use (UDU), including both illicit drug
use and misuse of prescription medications, is high
among Americans 12 or older (9.4% past month; 48%
lifetime), and is often 50-100% higher among emergency
department (ED) patients (Cherpitel & Ye, 2008). While
most screening, brief intervention and referral to treat-
ment (SBIRT) projects focus on questionnaire screening
for UDU, many clinicians are unaware of the potential
of saliva testing (ST) to increase detection.
The objective is toassess the added value of ST when
added to comprehensive questionnaire screening for
UDU.
Material and methods
Research assistants systematically approached adult
patients receiving care in the medical-surgical area of an
urban ED. After granting informed consent, patients com-
pleted a survey containing four different single-item drug
screening questions (SDSQs) and the drug use section of
the Mini International Neuropsychiatric Interview, then
received a financial incentive. Patients granting separate
consent then provided a saliva sample for drug testing and
received a second incentive.
Results
Among 208 patients interviewed, only 111 (53.4%)
agreed to saliva testing. Nine samples were positive in
patients not reporting illegal/recreational drug use. Six
were positive for prescribed medications which they had
reported (five for alprazolam, one for opioids). Two
were positive for undisclosed cocaine. One was positive
for barbiturates in a patient who did not report barbitu-
rate use.
Conclusions
ST detected two patients (1.8% of those submitting sam-
ples) with unsuspected illicit drug use and one patient
(0.9%) with unreported prescription psychotropic drug
use. Despite financial incentives, 47% of patients refused
ST, which could have disclosed more unreported drug
use. Results confirm the ability of biomarker testing to
detect small numbers of additional patients with poten-
tially life-threatening UDU when added to questionnaire
screening.
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